Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid

NCT00156169 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00156169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00156169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid
Lead sponsor
Sheba Medical Center
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2001
Completion date
December 31, 2006
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

low hdl cholesterol